- Record: found
- Abstract: found
- Article: not found
Platinum-based chemotherapy plus cetuximab in head and neck cancer.
Jan B Vermorken
1 ,
Ricard Mesia ,
Fernando Rivera ,
Eva Remenar ,
Andrzej Kawecki ,
Sylvie Rottey ,
Jozsef Erfan ,
Dmytro Zabolotnyy ,
Heinz-Roland Kienzer ,
Didier Cupissol ,
Frederic Peyrade ,
Marco Benasso ,
Ihor Vynnychenko ,
Dominique De Raucourt ,
Carsten Bokemeyer ,
Armin Schueler ,
Nadia Amellal ,
Ricardo Hitt
Sep 11 2008
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Cetuximab is effective in platinum-resistant recurrent or metastatic squamous-cell carcinoma of the head and neck. We investigated the efficacy of cetuximab plus platinum-based chemotherapy as first-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck.